Takeda and BioXcel partner to repurpose rare diseases compounds

BioXcel Corp, a provider of cloud-based Pharma big data solutions for discovering novel products, has entered into a partnership with Takeda Development Center Americas, a unit of Japan’s largest drugmaker Takeda Pharma (TYO: 4502), for the repurposing of assets across the gamut of rare diseases.

Through this partnership, Takeda will gain access to and leverage BioXcel’s Big Data Innovation Lab – an integrated product discovery engine – and PharmGPS Orphan Disease Suite for drug discovery and repurposing.